scispace - formally typeset
Open AccessJournal ArticleDOI

Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics.

Reads0
Chats0
TLDR
The mechanisms of action of some of the major herbal products with potential in the treatment of NDDs are reviewed according to their molecular targets, as well as their regional sources (Asia, America and Africa).
Abstract
Among the major neurodegenerative disorders (NDDs), Alzheimer’s disease (AD) and Parkinson’s disease (PD), are a huge socioeconomic burden. Over many centuries, people have sought a cure for NDDs from the natural herbals. Many medicinal plants and their secondary metabolites are reported with the ability to alleviate the symptoms of NDDs. The major mechanisms identified, through which phytochemicals exert their neuroprotective effects and potential maintenance of neurological health in ageing, include antioxidant, anti-inflammatory, antithrombotic, antiapoptotic, acetylcholinesterase and monoamine oxidase inhibition and neurotrophic activities. This article reviews the mechanisms of action of some of the major herbal products with potential in the treatment of NDDs according to their molecular targets, as well as their regional sources (Asia, America and Africa). A number of studies demonstrated the beneficial properties of plant extracts or their bioactive compounds against NDDs. Herbal products may potentially offer new treatment options for patients with NDDs, which is a cheaper and culturally suitable alternative to conventional therapies for millions of people in the world with age-related NDDs.

read more

Citations
More filters
References
More filters
Journal ArticleDOI

Natural Products as Sources of New Drugs from 1981 to 2014

TL;DR: This contribution is a completely updated and expanded version of the four prior analogous reviews that were published in this journal in 1997, 2003, 2007, and 2012, and the time frame has been extended to cover the 34 years from January 1, 1981, to December 31, 2014, for all diseases worldwide, and from 1950 (earliest so far identified) to December 2014 for all approved antitumor drugs worldwide.
Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (Chinese edition)

TL;DR: Provide a structured summary including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings, systematic review registration number 2.
Journal ArticleDOI

The cholinergic hypothesis of Alzheimer’s disease: a review of progress

TL;DR: The existing scientific applicability of the original cholinergic hypothesis of Alzheimer’s disease is examined by describing the biochemical and histopathological changes of neurotransmitter markers that occur in the brains of patients with Alzheimer's disease both at postmortem and neurosurgical cerebral biopsy and the behavioural consequences of cholinomimetic drugs andCholinergic lesions.
Journal ArticleDOI

Oxidative stress in Parkinson's disease

TL;DR: Oxidative stress contributes to the cascade leading to dopamine cell degeneration in Parkinson's disease (PD), but oxidative stress is intimately linked to other components of the degenerative process, such as mitochondrial dysfunction, excitotoxicity, nitric oxide toxicity and inflammation.
Related Papers (5)
Trending Questions (1)
What studies demonstrate effects of a botanical active on DEGs?

Studies have shown the beneficial effects of plant extracts or bioactive compounds on neurodegenerative disorders, highlighting their potential as alternative treatments for patients.